Surgical trial targets ‘inoperable’ pancreatic tumours

A clinical trial aims to offer a lifeline for patients facing advanced pancreatic cancer, traditionally considered beyond surgical intervention.

The study, led by Keck Medicine of the University of Southern California, seeks to determine whether a combination of chemotherapy followed by a novel surgical procedure could pave the way for improved outcomes for people with locally advanced pancreatic cancer.

This form of the disease indicates tumours that haven't spread but are closely positioned near adjacent blood vessels, making surgical removal risky.

Nullam et interdum sapien, eu facilisis erat. Etiam eget quam nisi. Integer imperdiet eros vel lorem pellentesque, non ornare libero aliquam. Phasellus nec urna molestie, pellentesque nisi at, volutpat odio. Mauris pulvinar efficitur neque at pretium. Nunc euismod turpis ante, et porttitor diam auctor sed. Ut erat metus, tincidunt a malesuada nec, blandit ut felis. Nullam pulvinar ac dolor at euismod. Curabitur scelerisque ac urna in cursus. Nulla nisi elit, consectetur a sem ac, laoreet condimentum massa
Register for free or to unlock this article
To gain full access to the only resource for industry news, simply register for free.
Already registered?
Connecting Surgeons.
Shaping the future.
connecting surgeons. shaping the future
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram